{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:03:24Z","timestamp":1780452204651,"version":"3.54.1"},"publisher-location":"Cham","reference-count":95,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319744698","type":"print"},{"value":"9783319744704","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-3-319-74470-4_4","type":"book-chapter","created":{"date-parts":[[2018,5,12]],"date-time":"2018-05-12T06:23:03Z","timestamp":1526106183000},"page":"47-59","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Targeting miRNA for Therapy of Juvenile and Adult Diabetic Cardiomyopathy"],"prefix":"10.1007","author":[{"given":"Shyam Sundar","family":"Nandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paras Kumar","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,13]]},"reference":[{"issue":"9","key":"4_CR1","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.2337\/diacare.21.9.1414","volume":"21","author":"H King","year":"1998","unstructured":"King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995\u20132025: prevalence, numerical estimates, and projections. Diabetes Care 21(9):1414\u20131431","journal-title":"Diabetes Care"},{"issue":"5","key":"4_CR2","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","volume":"27","author":"S Wild","year":"2004","unstructured":"Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27(5):1047\u20131053","journal-title":"Diabetes Care"},{"issue":"3","key":"4_CR3","first-page":"223","volume":"34","author":"S Shah","year":"2009","unstructured":"Shah S, Win Z, Al-Nahhas A (2009) Multiorgan dysfunctions in diabetic patients: the role of functional imaging. Minerva Endocrinol 34(3):223\u2013236","journal-title":"Minerva Endocrinol"},{"issue":"3","key":"4_CR4","first-page":"163","volume":"49","author":"GH Gluhovschi","year":"2011","unstructured":"Gluhovschi GH, Gluhovschi C, Vlad A, Timar R, Bob F, Velciov S et al (2011) Diabetic nephropathy and multiorgan protection. Part I. Rom J Intern Med 49(3):163\u2013177","journal-title":"Rom J Intern Med"},{"key":"4_CR5","doi-asserted-by":"publisher","first-page":"7292564","DOI":"10.1155\/2016\/7292564","volume":"2016","author":"C Sardu","year":"2016","unstructured":"Sardu C, Barbieri M, Rizzo MR, Paolisso P, Paolisso G, Marfella R (2016) Cardiac resynchronization therapy outcomes in type 2 diabetic patients: role of MicroRNA changes. J Diabetes Res 2016:7292564","journal-title":"J Diabetes Res"},{"issue":"Pt A","key":"4_CR6","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.phrs.2016.09.040","volume":"113","author":"P Balakumar","year":"2016","unstructured":"Balakumar P, Maung UK, Jagadeesh G (2016) Prevalence and prevention of cardiovascular disease and diabetes mellitus. Pharmacol Res 113(Pt A):600\u2013609","journal-title":"Pharmacol Res"},{"issue":"6","key":"4_CR7","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/pedi.12302","volume":"17","author":"F Ahmadizar","year":"2016","unstructured":"Ahmadizar F, Fazeli Farsani S, Souverein PC, van der Vorst MM, de Boer A, Maitland-van der Zee AH (2016) Cardiovascular medication use and cardiovascular disease in children and adolescents with type 1 diabetes: a population-based cohort study. Pediatr Diabetes 17(6):433\u2013440","journal-title":"Pediatr Diabetes"},{"issue":"3","key":"4_CR8","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nrendo.2015.216","volume":"12","author":"G Jia","year":"2016","unstructured":"Jia G, DeMarco VG, Sowers JR (2016) Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat Rev Endocrinol 12(3):144\u2013153","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"4_CR9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.beem.2016.05.003","volume":"30","author":"LM Jaacks","year":"2016","unstructured":"Jaacks LM, Siegel KR, Gujral UP, Narayan KM (2016) Type 2 diabetes: A 21st century epidemic. Best Pract Res Clin Endocrinol Metab 30(3):331\u2013343","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"4_CR10","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281\u2013297","journal-title":"Cell"},{"key":"4_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s40291-016-0234-z","volume":"21","author":"P Berber","year":"2016","unstructured":"Berber P, Grassmann F, Kiel C, Weber BH (2016) An eye on age-related macular degeneration: the role of microRNAs in disease pathology. Mol Diagn Ther 21:31","journal-title":"Mol Diagn Ther"},{"key":"4_CR12","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.abb.2015.09.018","volume":"589","author":"EJ Abente","year":"2016","unstructured":"Abente EJ, Subramanian M, Ramachandran V, Najafi-Shoushtari SH (2016) MicroRNAs in obesity-associated disorders. Arch Biochem Biophys 589:108\u2013119","journal-title":"Arch Biochem Biophys"},{"issue":"4","key":"4_CR13","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1161\/CIRCRESAHA.115.306300","volume":"118","author":"MW Feinberg","year":"2016","unstructured":"Feinberg MW, Moore KJ (2016) MicroRNA regulation of atherosclerosis. Circ Res 118(4):703\u2013720","journal-title":"Circ Res"},{"issue":"3","key":"4_CR14","doi-asserted-by":"publisher","first-page":"326","DOI":"10.7150\/ijbs.15017","volume":"12","author":"Y Li","year":"2016","unstructured":"Li Y, Sarkar FH (2016) MicroRNA targeted therapeutic approach for pancreatic cancer. Int J Biol Sci 12(3):326\u2013337","journal-title":"Int J Biol Sci"},{"issue":"3","key":"4_CR15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11892-016-0724-8","volume":"16","author":"K Simpson","year":"2016","unstructured":"Simpson K, Wonnacott A, Fraser DJ, Bowen T (2016) MicroRNAs in diabetic nephropathy: from biomarkers to therapy. Curr Diab Rep 16(3):35","journal-title":"Curr Diab Rep"},{"issue":"4","key":"4_CR16","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/j.1582-4934.2009.00744.x","volume":"13","author":"PK Mishra","year":"2009","unstructured":"Mishra PK, Tyagi N, Kumar M, Tyagi SC (2009) MicroRNAs as a therapeutic target for cardiovascular diseases. J Cell Mol Med 13(4):778\u2013789","journal-title":"J Cell Mol Med"},{"issue":"3","key":"4_CR17","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1177\/1074248415604463","volume":"21","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Chen Q, Lew KS, Richards AM, Wang P (2016) Discovery of potential therapeutic miRNA targets in cardiac ischemia-reperfusion injury. J Cardiovasc Pharmacol Ther 21(3):296\u2013309","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"6","key":"4_CR18","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.2337\/db11-0952","volume":"61","author":"S Greco","year":"2012","unstructured":"Greco S, Fasanaro P, Castelvecchio S, D'Alessandra Y, Arcelli D, Di Donato M et al (2012) MicroRNA dysregulation in diabetic ischemic heart failure patients. Diabetes 61(6):1633\u20131641","journal-title":"Diabetes"},{"issue":"6","key":"4_CR19","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2174\/157339911797579179","volume":"7","author":"AC Tyagi","year":"2011","unstructured":"Tyagi AC, Sen U, Mishra PK (2011) Synergy of microRNA and stem cell: a novel therapeutic approach for diabetes mellitus and cardiovascular diseases. Curr Diabetes Rev 7(6):367\u2013376","journal-title":"Curr Diabetes Rev"},{"key":"4_CR20","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1016\/j.bbalip.2016.01.010","volume":"1861","author":"A Caporali","year":"2016","unstructured":"Caporali A, Miscianinov V, Saif J, Emanueli C (2016) MicroRNA transport in cardiovascular complication of diabetes. Biochim Biophys Acta 1861:2111","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"4_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12013-013-9679-4","volume":"68","author":"V Chavali","year":"2014","unstructured":"Chavali V, Tyagi SC, Mishra PK (2014) Differential expression of dicer, miRNAs, and inflammatory markers in diabetic Ins2+\/\u2212 Akita hearts. Cell Biochem Biophys 68(1):25\u201335","journal-title":"Cell Biochem Biophys"},{"issue":"6","key":"4_CR22","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1093\/eurheartj\/ehv599","volume":"37","author":"S Costantino","year":"2016","unstructured":"Costantino S, Paneni F, Luscher TF, Cosentino F (2016) MicroRNA profiling unveils hyperglycaemic memory in the diabetic heart. Eur Heart J 37(6):572\u2013576","journal-title":"Eur Heart J"},{"issue":"6","key":"4_CR23","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1161\/ATVBAHA.114.305048","volume":"35","author":"S Dangwal","year":"2015","unstructured":"Dangwal S, Stratmann B, Bang C, Lorenzen JM, Kumarswamy R, Fiedler J et\u00a0al (2015) Impairment of wound healing in patients with type 2 diabetes mellitus influences circulating MicroRNA patterns via inflammatory cytokines. Arterioscler Thromb Vasc Biol 35(6):1480\u20131488","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"4_CR24","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s12013-013-9672-y","volume":"67","author":"SS Yildirim","year":"2013","unstructured":"Yildirim SS, Akman D, Catalucci D, Turan B (2013) Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: junctin as a target protein of miR-1. Cell Biochem Biophys 67(3):1397\u20131408","journal-title":"Cell Biochem Biophys"},{"issue":"6","key":"4_CR25","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1161\/CIRCRESAHA.110.226357","volume":"107","author":"A Zampetaki","year":"2010","unstructured":"Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M et al (2010) Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res 107(6):810\u2013817","journal-title":"Circ Res"},{"issue":"4","key":"4_CR26","first-page":"683","volume":"7","author":"SS Nandi","year":"2015","unstructured":"Nandi SS, Duryee MJ, Shahshahan HR, Thiele GM, Anderson DR, Mishra PK (2015) Induction of autophagy markers is associated with attenuation of miR-133a in diabetic heart failure patients undergoing mechanical unloading. Am J Transl Res 7(4):683\u2013696","journal-title":"Am J Transl Res"},{"issue":"10","key":"4_CR27","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.2337\/db16-0023","volume":"65","author":"SS Nandi","year":"2016","unstructured":"Nandi SS, Zheng H, Sharma NM, Shahshahan HR, Patel KP, Mishra PK (2016) Lack of miR-133a decreases contractility of diabetic hearts: a role for novel cross talk between tyrosine aminotransferase and tyrosine hydroxylase. Diabetes 65(10):3075\u20133090","journal-title":"Diabetes"},{"issue":"7","key":"4_CR28","doi-asserted-by":"publisher","first-page":"H954","DOI":"10.1152\/ajpheart.00835.2012","volume":"304","author":"ZA Malik","year":"2013","unstructured":"Malik ZA, Kott KS, Poe AJ, Kuo T, Chen L, Ferrara KW et al (2013) Cardiac myocyte exosomes: stability, HSP60, and proteomics. Am J Physiol Heart Circ Physiol 304(7):H954\u2013H965","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"5","key":"4_CR29","first-page":"1064","volume":"14","author":"KR Vrijsen","year":"2010","unstructured":"Vrijsen KR, Sluijter JP, Schuchardt MW, van Balkom BW, Noort WA, Chamuleau SA et al (2010) Cardiomyocyte progenitor cell-derived exosomes stimulate migration of endothelial cells. J Cell Mol Med 14(5):1064\u20131070","journal-title":"J Cell Mol Med"},{"issue":"4","key":"4_CR30","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.carpath.2015.04.007","volume":"24","author":"S Das","year":"2015","unstructured":"Das S, Halushka MK (2015) Extracellular vesicle microRNA transfer in cardiovascular disease. Cardiovasc Pathol 24(4):199\u2013206","journal-title":"Cardiovasc Pathol"},{"key":"4_CR31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s12015-016-9696-y","volume":"13","author":"P Prathipati","year":"2017","unstructured":"Prathipati P, Nandi SS, Mishra PK (2017) Stem cell-derived exosomes, autophagy, extracellular matrix turnover, and miRNAs in cardiac regeneration during stem cell therapy. Stem Cell Rev 13:79","journal-title":"Stem Cell Rev"},{"issue":"2","key":"4_CR32","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1161\/CIRCRESAHA.114.300584","volume":"114","author":"A Waldenstrom","year":"2014","unstructured":"Waldenstrom A, Ronquist G (2014) Role of exosomes in myocardial remodeling. Circ Res 114(2):315\u2013324","journal-title":"Circ Res"},{"key":"4_CR33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ijcard.2014.10.144","volume":"178","author":"T Yamaguchi","year":"2015","unstructured":"Yamaguchi T, Izumi Y, Nakamura Y, Yamazaki T, Shiota M, Sano S et al (2015) Repeated remote ischemic conditioning attenuates left ventricular remodeling via exosome-mediated intercellular communication on chronic heart failure after myocardial infarction. Int J Cardiol 178:239\u2013246","journal-title":"Int J Cardiol"},{"issue":"9833","key":"4_CR34","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","volume":"379","author":"AG Tabak","year":"2012","unstructured":"Tabak AG, Herder C, Rathmann W, Brunner EJ, Kivimaki M (2012) Prediabetes: a high-risk state for diabetes development. Lancet 379(9833):2279\u20132290","journal-title":"Lancet"},{"issue":"2","key":"4_CR35","first-page":"206","volume":"31","author":"J Karalliedde","year":"2016","unstructured":"Karalliedde J, Gnudi L (2016) Diabetes mellitus, a complex and heterogeneous disease, and the role of insulin resistance as a determinant of diabetic kidney disease. Nephrol Dial Transplant 31(2):206\u2013213","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"4_CR36","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.2337\/dc08-zb09","volume":"31","author":"ZT Bloomgarden","year":"2008","unstructured":"Bloomgarden ZT (2008) Glycemic control in diabetes: a tale of three studies. Diabetes Care 31(9):1913\u20131919","journal-title":"Diabetes Care"},{"key":"4_CR37","doi-asserted-by":"publisher","first-page":"461","DOI":"10.2741\/3630","volume":"15","author":"PK Mishra","year":"2010","unstructured":"Mishra PK, Singh SR, Joshua IG, Tyagi SC (2010) Stem cells as a therapeutic target for diabetes. Front Biosci (Landmark Ed) 15:461\u2013477","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"6","key":"4_CR38","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","volume":"30","author":"S Rubler","year":"1972","unstructured":"Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A (1972) New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 30(6):595\u2013602","journal-title":"Am J Cardiol"},{"key":"4_CR39","first-page":"151","volume":"6","author":"V Chavali","year":"2013","unstructured":"Chavali V, Tyagi SC, Mishra PK (2013) Predictors and prevention of diabetic cardiomyopathy. Diabetes Metab Syndr Obes 6:151\u2013160","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"6","key":"4_CR40","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3810\/pgm.2012.11.2615","volume":"124","author":"C Campos","year":"2012","unstructured":"Campos C (2012) Chronic hyperglycemia and glucose toxicity: pathology and clinical sequelae. Postgrad Med 124(6):90\u201397","journal-title":"Postgrad Med"},{"key":"4_CR41","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fendo.2012.00170","volume":"3","author":"DV Nguyen","year":"2012","unstructured":"Nguyen DV, Shaw LC, Grant MB (2012) Inflammation in the pathogenesis of microvascular complications in diabetes. Front Endocrinol (Lausanne) 3:170","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"4_CR42","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/j.1463-1326.2006.00655.x","volume":"9","author":"S Rahman","year":"2007","unstructured":"Rahman S, Rahman T, Ismail AA, Rashid AR (2007) Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis. Diabetes Obes Metab 9(6):767\u2013780","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"4_CR43","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1161\/01.CIR.0000109693.64957.20","volume":"109","author":"V Mathew","year":"2004","unstructured":"Mathew V, Gersh BJ, Williams BA, Laskey WK, Willerson JT, Tilbury RT et al (2004) Outcomes in patients with diabetes mellitus undergoing percutaneous coronary intervention in the current era: a report from the Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation 109(4):476\u2013480","journal-title":"Circulation"},{"issue":"6","key":"4_CR44","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.2337\/dc10-0555","volume":"33","author":"M Pignone","year":"2010","unstructured":"Pignone M, Alberts MJ, Colwell JA, Cushman M, Inzucchi SE, Mukherjee D et al (2010) Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation. Diabetes Care 33(6):1395\u20131402","journal-title":"Diabetes Care"},{"key":"4_CR45","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.freeradbiomed.2015.11.013","volume":"90","author":"R Ni","year":"2016","unstructured":"Ni R, Cao T, Xiong S, Ma J, Fan GC, Lacefield JC et al (2016) Therapeutic inhibition of mitochondrial reactive oxygen species with mito-TEMPO reduces diabetic cardiomyopathy. Free Radic Biol Med 90:12\u201323","journal-title":"Free Radic Biol Med"},{"key":"4_CR46","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.bbadis.2016.08.021","volume":"1863","author":"SK Verma","year":"2017","unstructured":"Verma SK, Garikipati VN, Kishore R (2017) Mitochondrial dysfunction and its impact on diabetic heart. Biochim Biophys Acta 1863:1098","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"4_CR47","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.2337\/db08-0079","volume":"57","author":"H Bugger","year":"2008","unstructured":"Bugger H, Boudina S, Hu XX, Tuinei J, Zaha VG, Theobald HA et al (2008) Type 1 diabetic akita mouse hearts are insulin sensitive but manifest structurally abnormal mitochondria that remain coupled despite increased uncoupling protein 3. Diabetes 57(11):2924\u20132932","journal-title":"Diabetes"},{"issue":"12","key":"4_CR48","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s00210-013-0904-x","volume":"386","author":"A Taye","year":"2013","unstructured":"Taye A, Abouzied MM, Mohafez OM (2013) Tempol ameliorates cardiac fibrosis in streptozotocin-induced diabetic rats: role of oxidative stress in diabetic cardiomyopathy. Naunyn Schmiedeberg\u2019s Arch Pharmacol 386(12):1071\u20131080","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"issue":"3","key":"4_CR49","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3892\/ijmm.2014.1614","volume":"33","author":"J Chen","year":"2014","unstructured":"Chen J, Mo H, Guo R, You Q, Huang R, Wu K (2014) Inhibition of the leptin-induced activation of the p38 MAPK pathway contributes to the protective effects of naringin against high glucose-induced injury in H9c2 cardiac cells. Int J Mol Med 33(3):605\u2013612","journal-title":"Int J Mol Med"},{"issue":"3","key":"4_CR50","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s12013-009-9063-6","volume":"55","author":"PK Mishra","year":"2009","unstructured":"Mishra PK, Tyagi N, Kundu S, Tyagi SC (2009) MicroRNAs are involved in homocysteine-induced cardiac remodeling. Cell Biochem Biophys 55(3):153\u2013162","journal-title":"Cell Biochem Biophys"},{"key":"4_CR51","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1475-2840-9-49","volume":"9","author":"PK Mishra","year":"2010","unstructured":"Mishra PK, Tyagi N, Sen U, Joshua IG, Tyagi SC (2010) Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol. Cardiovasc Diabetol 9:49","journal-title":"Cardiovasc Diabetol"},{"key":"4_CR52","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fphys.2016.00093","volume":"7","author":"P Prathipati","year":"2016","unstructured":"Prathipati P, Metreveli N, Nandi SS, Tyagi SC, Mishra PK (2016) Ablation of matrix metalloproteinase-9 prevents cardiomyocytes contractile dysfunction in diabetics. Front Physiol 7:93","journal-title":"Front Physiol"},{"issue":"1-2","key":"4_CR53","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11010-016-2729-7","volume":"417","author":"SK Raut","year":"2016","unstructured":"Raut SK, Singh GB, Rastogi B, Saikia UN, Mittal A, Dogra N et al (2016) miR-30c and miR-181a synergistically modulate p53-p21 pathway in diabetes induced cardiac hypertrophy. Mol Cell Biochem 417(1-2):191\u2013203","journal-title":"Mol Cell Biochem"},{"issue":"Pt A","key":"4_CR54","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.yjmcc.2014.12.014","volume":"89","author":"C Beltrami","year":"2015","unstructured":"Beltrami C, Angelini TG, Emanueli C (2015) Noncoding RNAs in diabetes vascular complications. J Mol Cell Cardiol 89(Pt A):42\u201350","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"4_CR55","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/dmrr.1054","volume":"26","author":"B Feng","year":"2010","unstructured":"Feng B, Chen S, George B, Feng Q, Chakrabarti S (2010) miR133a regulates cardiomyocyte hypertrophy in diabetes. Diabetes Metab Res Rev 26(1):40\u201349","journal-title":"Diabetes Metab Res Rev"},{"issue":"1-2","key":"4_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mrfmmm.2011.03.009","volume":"717","author":"MI Almeida","year":"2011","unstructured":"Almeida MI, Reis RM, Calin GA (2011) MicroRNA history: discovery, recent applications, and next frontiers. Mutat Res 717(1-2):1\u20138","journal-title":"Mutat Res"},{"issue":"4","key":"4_CR57","doi-asserted-by":"publisher","first-page":"R57","DOI":"10.1186\/gb-2014-15-4-r57","volume":"15","author":"MR Friedlander","year":"2014","unstructured":"Friedlander MR, Lizano E, Houben AJ, Bezdan D, Banez-Coronel M, Kudla G et al (2014) Evidence for the biogenesis of more than 1,000 novel human microRNAs. Genome Biol 15(4):R57","journal-title":"Genome Biol"},{"issue":"5","key":"4_CR58","doi-asserted-by":"publisher","first-page":"e62589","DOI":"10.1371\/journal.pone.0062589","volume":"8","author":"Y Hashimoto","year":"2013","unstructured":"Hashimoto Y, Akiyama Y, Yuasa Y (2013) Multiple-to-multiple relationships between microRNAs and target genes in gastric cancer. PLoS One 8(5):e62589","journal-title":"PLoS One"},{"issue":"6","key":"4_CR59","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1161\/CIRCRESAHA.113.300226","volume":"113","author":"R Kumarswamy","year":"2013","unstructured":"Kumarswamy R, Thum T (2013) Non-coding RNAs in cardiac remodeling and heart failure. Circ Res 113(6):676\u2013689","journal-title":"Circ Res"},{"issue":"18","key":"4_CR60","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.4161\/cc.7.18.6734","volume":"7","author":"K Okamura","year":"2008","unstructured":"Okamura K, Chung WJ, Lai EC (2008) The long and short of inverted repeat genes in animals: microRNAs, mirtrons and hairpin RNAs. Cell Cycle 7(18):2840\u20132845","journal-title":"Cell Cycle"},{"issue":"12","key":"4_CR61","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1161\/CIRCULATIONAHA.110.982918","volume":"123","author":"T Hosoda","year":"2011","unstructured":"Hosoda T, Zheng H, Cabral-da-Silva M, Sanada F, Ide-Iwata N, Ogorek B et al (2011) Human cardiac stem cell differentiation is regulated by a mircrine mechanism. Circulation 123(12):1287\u20131296","journal-title":"Circulation"},{"issue":"2","key":"4_CR62","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ydbio.2008.11.016","volume":"326","author":"KM Foshay","year":"2009","unstructured":"Foshay KM, Gallicano GI (2009) miR-17 family miRNAs are expressed during early mammalian development and regulate stem cell differentiation. Dev Biol 326(2):431\u2013443","journal-title":"Dev Biol"},{"issue":"5","key":"4_CR63","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2174\/1566524011313050007","volume":"13","author":"KT Kuppusamy","year":"2013","unstructured":"Kuppusamy KT, Sperber H, Ruohola-Baker H (2013) MicroRNA regulation and role in stem cell maintenance, cardiac differentiation and hypertrophy. Curr Mol Med 13(5):757\u2013764","journal-title":"Curr Mol Med"},{"issue":"8","key":"4_CR64","first-page":"492","volume":"12","author":"P Sartipy","year":"2009","unstructured":"Sartipy P, Olsson B, Hyllner J, Synnergren J (2009) Regulation of \u2018stemness\u2019 and stem cell differentiation by microRNAs. IDrugs 12(8):492\u2013496","journal-title":"IDrugs"},{"issue":"5995","key":"4_CR65","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1126\/science.1191035","volume":"329","author":"PM Gilbert","year":"2010","unstructured":"Gilbert PM, Havenstrite KL, Magnusson KE, Sacco A, Leonardi NA, Kraft P et al (2010) Substrate elasticity regulates skeletal muscle stem cell self-renewal in culture. Science 329(5995):1078\u20131081","journal-title":"Science"},{"issue":"3","key":"4_CR66","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1139\/y11-131","volume":"90","author":"PK Mishra","year":"2012","unstructured":"Mishra PK, Chavali V, Metreveli N, Tyagi SC (2012) Ablation of MMP9 induces survival and differentiation of cardiac stem cells into cardiomyocytes in the heart of diabetics: a role of extracellular matrix. Can J Physiol Pharmacol 90(3):353\u2013360","journal-title":"Can J Physiol Pharmacol"},{"issue":"12","key":"4_CR67","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1016\/j.bbadis.2013.09.004","volume":"1832","author":"PK Mishra","year":"2013","unstructured":"Mishra PK, Givvimani S, Chavali V, Tyagi SC (2013) Cardiac matrix: a clue for future therapy. Biochim Biophys Acta 1832(12):2271\u20132276","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"4_CR68","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.stem.2008.01.016","volume":"2","author":"KN Ivey","year":"2008","unstructured":"Ivey KN, Muth A, Arnold J, King FW, Yeh RF, Fish JE et al (2008) MicroRNA regulation of cell lineages in mouse and human embryonic stem cells. Cell Stem Cell 2(3):219\u2013229","journal-title":"Cell Stem Cell"},{"issue":"5","key":"4_CR69","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1161\/CIRCGENETICS.109.934281","volume":"3","author":"KD Wilson","year":"2010","unstructured":"Wilson KD, Hu S, Venkatasubrahmanyam S, Fu JD, Sun N, Abilez OJ et al (2010) Dynamic microRNA expression programs during cardiac differentiation of human embryonic stem cells: role for miR-499. Circ Cardiovasc Genet 3(5):426\u2013435","journal-title":"Circ Cardiovasc Genet"},{"issue":"8","key":"4_CR70","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1161\/ATVBAHA.113.300138","volume":"33","author":"FH Seeger","year":"2013","unstructured":"Seeger FH, Zeiher AM, Dimmeler S (2013) MicroRNAs in stem cell function and regenerative therapy of the heart. Arterioscler Thromb Vasc Biol 33(8):1739\u20131746","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"4_CR71","doi-asserted-by":"publisher","first-page":"e63041","DOI":"10.1371\/journal.pone.0063041","volume":"8","author":"L Bras-Rosario","year":"2013","unstructured":"Bras-Rosario L, Matsuda A, Pinheiro AI, Gardner R, Lopes T, Amaral A et al (2013) Expression profile of microRNAs regulating proliferation and differentiation in mouse adult cardiac stem cells. PLoS One 8(5):e63041","journal-title":"PLoS One"},{"issue":"3","key":"4_CR72","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrcardio.2014.207","volume":"12","author":"RA Boon","year":"2015","unstructured":"Boon RA, Dimmeler S (2015) MicroRNAs in myocardial infarction. Nat Rev Cardiol 12(3):135\u2013142","journal-title":"Nat Rev Cardiol"},{"issue":"13","key":"4_CR73","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.2174\/138161212799859620","volume":"18","author":"S Crippa","year":"2012","unstructured":"Crippa S, Cassano M, Sampaolesi M (2012) Role of miRNAs in muscle stem cell biology: proliferation, differentiation and death. Curr Pharm Des 18(13):1718\u20131729","journal-title":"Curr Pharm Des"},{"issue":"10","key":"4_CR74","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1161\/CIRCRESAHA.116.304377","volume":"116","author":"CP Hodgkinson","year":"2015","unstructured":"Hodgkinson CP, Kang MH, Dal-Pra S, Mirotsou M, Dzau VJ (2015) MicroRNAs and cardiac regeneration. Circ Res 116(10):1700\u20131711","journal-title":"Circ Res"},{"issue":"2","key":"4_CR75","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4330\/wjc.v8.i2.163","volume":"8","author":"JA Kamps","year":"2016","unstructured":"Kamps JA, Krenning G (2016) Micromanaging cardiac regeneration: targeted delivery of microRNAs for cardiac repair and regeneration. World J Cardiol 8(2):163\u2013179","journal-title":"World J Cardiol"},{"issue":"6","key":"4_CR76","doi-asserted-by":"publisher","first-page":"441","DOI":"10.2174\/1389557515666150324123913","volume":"15","author":"Z Lei","year":"2015","unstructured":"Lei Z, Sluijter JP, van Mil A (2015) MicroRNA therapeutics for cardiac regeneration. Mini Rev Med Chem 15(6):441\u2013451","journal-title":"Mini Rev Med Chem"},{"key":"4_CR77","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.addr.2015.05.014","volume":"88","author":"B Peng","year":"2015","unstructured":"Peng B, Chen Y, Leong KW (2015) MicroRNA delivery for regenerative medicine. Adv Drug Deliv Rev 88:108\u2013122","journal-title":"Adv Drug Deliv Rev"},{"issue":"9","key":"4_CR78","doi-asserted-by":"publisher","first-page":"E918","DOI":"10.21037\/jtd.2016.08.93","volume":"8","author":"K Zhu","year":"2016","unstructured":"Zhu K, Liu D, Lai H, Li J, Wang C (2016) Developing miRNA therapeutics for cardiac repair in ischemic heart disease. J Thorac Dis 8(9):E918\u2013EE27","journal-title":"J Thorac Dis"},{"issue":"3","key":"4_CR79","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.scr.2009.12.003","volume":"4","author":"RC Lai","year":"2010","unstructured":"Lai RC, Arslan F, Lee MM, Sze NS, Choo A, Chen TS et al (2010) Exosome secreted by MSC reduces myocardial ischemia\/reperfusion injury. Stem Cell Res 4(3):214\u2013222","journal-title":"Stem Cell Res"},{"key":"4_CR80","doi-asserted-by":"crossref","first-page":"7653489","DOI":"10.1155\/2016\/7653489","volume":"2016","author":"C Han","year":"2016","unstructured":"Han C, Sun X, Liu L, Jiang H, Shen Y, Xu X et al (2016) Exosomes and their therapeutic potentials of stem cells. Stem Cells Int 2016:7653489","journal-title":"Stem Cells Int"},{"issue":"5","key":"4_CR81","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1172\/JCI70577","volume":"124","author":"C Bang","year":"2014","unstructured":"Bang C, Batkai S, Dangwal S, Gupta SK, Foinquinos A, Holzmann A et al (2014) Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J Clin Invest 124(5):2136\u20132146","journal-title":"J Clin Invest"},{"issue":"9","key":"4_CR82","doi-asserted-by":"publisher","first-page":"297","DOI":"10.4252\/wjsc.v8.i9.297","volume":"8","author":"E Suzuki","year":"2016","unstructured":"Suzuki E, Fujita D, Takahashi M, Oba S, Nishimatsu H (2016) Stem cell-derived exosomes as a therapeutic tool for cardiovascular disease. World J Stem Cells 8(9):297\u2013305","journal-title":"World J Stem Cells"},{"issue":"1","key":"4_CR83","first-page":"16","volume":"31","author":"C Iaconetti","year":"2016","unstructured":"Iaconetti C, Sorrentino S, De Rosa S, Indolfi C (2016) Exosomal miRNAs in heart disease. Physiology (Bethesda) 31(1):16\u201324","journal-title":"Physiology (Bethesda)"},{"issue":"2","key":"4_CR84","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1161\/CIRCRESAHA.115.307654","volume":"118","author":"R Kishore","year":"2016","unstructured":"Kishore R, Khan M (2016) More than tiny sacks: stem cell exosomes as cell-free modality for cardiac repair. Circ Res 118(2):330\u2013343","journal-title":"Circ Res"},{"issue":"2","key":"4_CR85","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3390\/ijms17020174","volume":"17","author":"B Zhang","year":"2016","unstructured":"Zhang B, Yeo RW, Tan KH, Lim SK (2016) Focus on extracellular vesicles: therapeutic potential of stem cell-derived extracellular vesicles. Int J Mol Sci 17(2):174","journal-title":"Int J Mol Sci"},{"issue":"10","key":"4_CR86","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.2337\/dbi16-0041","volume":"65","author":"S Sahoo","year":"2016","unstructured":"Sahoo S, Emanueli C (2016) Exosomes in diabetic cardiomyopathy: the next-generation therapeutic targets? Diabetes 65(10):2829\u20132831","journal-title":"Diabetes"},{"issue":"10","key":"4_CR87","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.2337\/db15-1563","volume":"65","author":"X Wang","year":"2016","unstructured":"Wang X, Gu H, Huang W, Peng J, Li Y, Yang L et al (2016) Hsp20-mediated activation of exosome biogenesis in cardiomyocytes improves cardiac function and angiogenesis in diabetic mice. Diabetes 65(10):3111\u20133128","journal-title":"Diabetes"},{"key":"4_CR88","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.yjmcc.2014.05.001","volume":"74","author":"X Wang","year":"2014","unstructured":"Wang X, Huang W, Liu G, Cai W, Millard RW, Wang Y et al (2014) Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the exosomal transfer of miR-320 into endothelial cells. J Mol Cell Cardiol 74:139\u2013150","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"4_CR89","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1042\/CS20130079","volume":"126","author":"AD McClelland","year":"2014","unstructured":"McClelland AD, Kantharidis P (2014) microRNA in the development of diabetic complications. Clin Sci (Lond) 126(2):95\u2013110","journal-title":"Clin Sci (Lond)"},{"issue":"8","key":"4_CR90","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1007\/s00125-015-3622-8","volume":"58","author":"D Zheng","year":"2015","unstructured":"Zheng D, Ma J, Yu Y, Li M, Ni R, Wang G et al (2015) Silencing of miR-195 reduces diabetic cardiomyopathy in C57BL\/6 mice. Diabetologia 58(8):1949\u20131958","journal-title":"Diabetologia"},{"issue":"3","key":"4_CR91","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/1755-5922.12113","volume":"33","author":"SK Raut","year":"2015","unstructured":"Raut SK, Kumar A, Singh GB, Nahar U, Sharma V, Mittal A et al (2015) miR-30c mediates upregulation of Cdc42 and Pak1 in diabetic cardiomyopathy. Cardiovasc Ther 33(3):89\u201397","journal-title":"Cardiovasc Ther"},{"issue":"12","key":"4_CR92","doi-asserted-by":"publisher","first-page":"C1244","DOI":"10.1152\/ajpcell.00137.2012","volume":"303","author":"WA Baseler","year":"2012","unstructured":"Baseler WA, Thapa D, Jagannathan R, Dabkowski ER, Croston TL, Hollander JM (2012) miR-141 as a regulator of the mitochondrial phosphate carrier (Slc25a3) in the type 1 diabetic heart. Am J Physiol Cell Physiol 303(12):C1244\u2013C1251","journal-title":"Am J Physiol Cell Physiol"},{"issue":"3","key":"4_CR93","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.bbrc.2012.07.105","volume":"425","author":"V Chavali","year":"2012","unstructured":"Chavali V, Tyagi SC, Mishra PK (2012) MicroRNA-133a regulates DNA methylation in diabetic cardiomyocytes. Biochem Biophys Res Commun 425(3):668\u2013672","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"4_CR94","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/jcmm.12218","volume":"18","author":"S Chen","year":"2014","unstructured":"Chen S, Puthanveetil P, Feng B, Matkovich SJ, Dorn GW 2nd, Chakrabarti S (2014) Cardiac miR-133a overexpression prevents early cardiac fibrosis in diabetes. J Cell Mol Med 18(3):415\u2013421","journal-title":"J Cell Mol Med"},{"issue":"7","key":"4_CR95","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1080\/15548627.2015.1051295","volume":"11","author":"H Kanamori","year":"2015","unstructured":"Kanamori H, Takemura G, Goto K, Tsujimoto A, Mikami A, Ogino A et al (2015) Autophagic adaptations in diabetic cardiomyopathy differ between type 1 and type 2 diabetes. Autophagy 11(7):1146\u20131160","journal-title":"Autophagy"}],"container-title":["Advances in Experimental Medicine and Biology","Exosomes, Stem Cells and MicroRNA"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-74470-4_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T13:17:48Z","timestamp":1751635068000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-74470-4_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9783319744698","9783319744704"],"references-count":95,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-74470-4_4","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}